Skip to main content

Discontinuation Cluster · SSRI

Paxil (Paroxetine) Onsite Taper

Onsite paroxetine (Paxil) taper — the SSRI most associated with severe discontinuation syndrome — bridged with full-spectrum iboga TA.

Generic name

Paroxetine

Drug class

SSRI

Half-life class

short

Plasma half-life

≈ 21 hours (no active metabolite)

Typical dose range

10–60 mg/day

Onsite taper duration

14–28 days onsite (longest of the SSRI class)

TA bridge

Iboga TA 75–150 mg BID (sub-psychoactive)

DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 1,000 patients treated.
Last reviewed: May 2026 · See full medical team

Quick Answer

Can I taper off Paxil (Paroxetine) at MindScape?

Yes. MindScape's onsite taper protocol discontinues Paxil (Paroxetine) under continuous cardiac telemetry by bridging with sub-psychoactive doses (75–150 mg BID (sub-psychoactive)) of full-spectrum iboga total alkaloid (TA) — covering all 12+ indole alkaloids — rather than benzodiazepine cover or unsupervised home washouts. Onsite taper duration is typically 14–28 days onsite (longest of the SSRI class), driven by the drug's short half-life and the patient's baseline dose. Eligible patients can then proceed to a flood-dose ibogaine HCl reset.

Reviewed by Dr. Arellano, M.D. — May 2026

Withdrawal Profile

  • Severe brain zaps (worst of the SSRI class)
  • Profound dizziness and vertigo
  • Anxiety crises, panic, derealization
  • Anticholinergic rebound — sweating, flushing, GI urgency
  • Insomnia, vivid dreams, nightmares

Why It's Hard To Taper At Home

  • Paroxetine has no active metabolite to soften the falloff and is highly anticholinergic.
  • Discontinuation syndrome onset within 24–48 hours of dose drop.
  • Hyperbolic micro-tapering is essential — linear tapers almost always fail.
  • Frequently misdiagnosed as anxiety relapse, leading to reinstatement.

MindScape Onsite Protocol

  1. Aggressive hyperbolic taper using compounded liquid: 50% step reductions every 5–10 days.
  2. Iboga TA bridge 75–150 mg BID — paroxetine taper requires the higher end of TA bridge dosing.
  3. Continuous cardiac telemetry; anticholinergic-rebound monitoring.
  4. Symptom-driven adjuncts: hydroxyzine, ondansetron, magnesium, electrolyte support.

Day-By-Day Patient Experience

  • Days 1–4: workup, magnesium loading, first reduction with strong TA cover.
  • Days 5–14: slowest hyperbolic step-downs; the protocol your home doctor probably can't deliver.
  • Days 15–22: full discontinuation; integration begins.
  • Days 23–28: optional ibogaine HCl flood for eligible candidates and post-flood telemetry.

Day-counts and step-cadences are illustrative ranges, not personal medical advice. Individual taper duration is determined onsite by the medical team after baseline workup.

Citations & Reading

  • Horowitz MA, Taylor D. (2019). Lancet Psychiatry, 6(6), 538-546.
  • Fava GA, et al. (2015). Psychotherapy and Psychosomatics, 84(2), 72-81.

For the broader iboga-TA evidence base, see the 2026 evidence-base review and the onsite taper cohort methodology page.

Other SSRI taper guides

Onsite Tapers

Ready to discuss a Paxil onsite taper?

Our medical team takes clinical calls from prospective patients, family members, and referring clinicians.

Schedule a clinical call

100% Confidential · No Obligation